Skip to main content
Clinical Trials/CTRI/2022/09/045640
CTRI/2022/09/045640
Active, Not Recruiting
N/A

A clinical investigation evaluating the presence and severity of Diabetic foot neuropathy using VIBRASENSE

Ayati Devices Private Limited0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Sponsor
Ayati Devices Private Limited
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Ayati Devices Private Limited

Eligibility Criteria

Inclusion Criteria

  • Type 1 diabetes over 5 years
  • Type 2 diabetes of any durartion with or withou history of diagnosed diabetic peripheral neuropathy confirmed by medical records
  • Patients who will be able to give written consent

Exclusion Criteria

  • Active foot ulceration
  • Visual evidence of recently healed foot ulceration
  • Lower limb amputation of any kind or diagnosed peripheral neuropathy of any origin other than diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials